Correlation Between Hard To and Arcus Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hard To and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hard To and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hard to Treat and Arcus Biosciences, you can compare the effects of market volatilities on Hard To and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hard To with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hard To and Arcus Biosciences.

Diversification Opportunities for Hard To and Arcus Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Hard and Arcus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hard to Treat and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Hard To is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hard to Treat are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Hard To i.e., Hard To and Arcus Biosciences go up and down completely randomly.

Pair Corralation between Hard To and Arcus Biosciences

If you would invest  1,495  in Arcus Biosciences on September 24, 2024 and sell it today you would earn a total of  55.00  from holding Arcus Biosciences or generate 3.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.31%
ValuesDaily Returns

Hard to Treat  vs.  Arcus Biosciences

 Performance 
       Timeline  
Hard to Treat 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hard to Treat has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Hard To is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Arcus Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arcus Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Hard To and Arcus Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hard To and Arcus Biosciences

The main advantage of trading using opposite Hard To and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hard To position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.
The idea behind Hard to Treat and Arcus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities